Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-07-25

FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Desmopressin acetate by Meitheal Pharmaceuticals, resulting in a label update associated with the supplemental appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DDAVP (Desmopressin acetate) (Desmopressin acetate)

Snippet

SUPPL AP for DESMOPRESSIN ACETATE (DESMOPRESSIN ACETATE)